Milestone Scientific, Inc. (MLSS) financial statements (2020 and earlier)

Company profile

Business Address 220 SOUTH ORANGE AVENUE
LIVINGSTON, NJ 07039
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21344101
Cash and cash equivalents21344101
Receivables2243222
Inventory, net of allowances, customer advances and progress billings2235421
Inventory2235421
Deferred costs 011   
Advances on inventory purchases1111111
Other undisclosed current assets1000000
Total current assets:66121312165
Noncurrent Assets
Property, plant and equipment0000000
Long-term investments and receivables  1  11
Long-term investments     11
Accounts and financing receivable, after allowance for credit loss  1    
Intangible assets, net (including goodwill)0031111
Intangible assets, net (excluding goodwill)0031111
Other noncurrent assets0000000
Other undisclosed noncurrent assets    002
Total noncurrent assets:0141123
TOTAL ASSETS:76161413178
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2334412
Accounts payable1113212
Accrued liabilities11212  
Debt0      
Due to related parties121    
Deferred revenue and credits21   
Contract with customer, liability0
Other undisclosed current liabilities101  11
Total current liabilities:5575423
Noncurrent Liabilities
Other undisclosed noncurrent liabilities  1  0 
Total noncurrent liabilities:  1  0 
Total liabilities:5585423
Stockholders' equity
Stockholders' equity attributable to parent, including:227910156
Preferred stock 000   
Common stock0000000
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital96888783797867
Accumulated deficit(94)(86)(79)(73)(67)(62)(60)
Other undisclosed stockholders' equity attributable to parent    000
Stockholders' equity attributable to noncontrolling interest(0)(0)00(1)0 
Total stockholders' equity:22899156
Other undisclosed liabilities and equity     (0) 
TOTAL LIABILITIES AND EQUITY:76161413178

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues810111091010
Revenue, net111091010
Cost of revenue
(Cost of Goods and Services Sold)
(3)(5)(4)(4)(3)(4)(3)
Gross profit:6476677
Operating expenses(10)(12)(12)(13)(10)(7)(6)
Other operating expense, net
(Other Expenses)
      (0)
Other undisclosed operating income      0
Operating income (loss):(4)(8)(5)(7)(3)(1)1
Nonoperating income (expense)(4)00(0)(0)(1)0
Investment income, nonoperating(4)000000
Other nonoperating income (expense)(0)(0)(0)(0)(0) 0
Interest and debt expense     (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes0      
Income (loss) from continuing operations before equity method investments, income taxes:(8)(8)(5)(7)(3)(2)1
Income (loss) from equity method investments00(0)(1)(2) (1)
Other undisclosed income from continuing operations before income taxes     0 
Income (loss) from continuing operations before income taxes:(8)(8)(5)(7)(6)(2)0
Income tax expense (benefit)(0)(0)(0)0(0)(0) 
Income (loss) before gain (loss) on sale of properties:(8)(8)(5)(7)(6)(2)0
Other undisclosed net income 0    1
Net income (loss):(8)(8)(5)(7)(6)(2)1
Net income attributable to noncontrolling interest000100 
Net income (loss) available to common stockholders, diluted:(8)(7)(5)(6)(5)(2)1

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(8)(8)(5)(7)(6)(2)1
Comprehensive income (loss):(8)(8)(5)(7)(6)(2)1
Comprehensive income, net of tax, attributable to noncontrolling interest000100 
Comprehensive income (loss), net of tax, attributable to parent:(8)(7)(5)(6)(5)(2)1

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: